Emerging spectrum of post-COVID-19 syndrome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34880080.
- Also identified by DOI 10.1136/postgradmedj-2020-139585.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
'Post-COVID-19 syndrome' refers to symptoms in the convalescent phase following initial COVID-19 infection. This term encompasses a wide array of presentation involving lungs, heart and the neuromuscular system. Pulmonary manifestations include post-COVID-19 fibrosis, which is akin to post acute respiratory distress syndrome fibrosis and may reflect the permanent damage to the lungs following an initial bout of infection. Cardiovascular system is often involved, and the presentation can be in terms of acute coronary syndrome, myocarditis and heart failure. Clinical manifestations are often varied and non-specific, which entails a detailed workup and a multidisciplinary approach. Post-COVID-19 syndrome adds to the overall disease morbidity and leads to a prolonged hospital stay, greater healthcare utilisation and loss of productivity marring the country's dwindling economy. Thus, it is imperative that post-COVID-19 syndrome be prevented and identified early followed by a prompt treatment.
Medical subject headings
- Acute Coronary Syndrome
- COVID-19
- COVID-19/complications
- Fibrosis
- Humans
- Myocarditis
- Myocarditis/diagnosis
- Myocarditis/therapy
- SARS-CoV-2